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Abstract: 
Among all classes of drugs, the type 5 phosphodiesterase inhibitors (PDE5-i) (sildenafil, 
vardenafil and tadalafil) are the most counterfeited and copied in industrialized countries. 
This is why it is very important for regulatory agencies to have a panel of analytical methods 
to analyse these drugs and to be able to detect counterfeit or substandard medicines. 
During this chapter, several analytical techniques will be described and discussed. Among 
spectroscopic techniques, Raman, NIR, FT-IR and chemical imaging techniques will be 
envisaged. Their ability to detect counterfeits and predict if a new sample is genuine or not 
will be presented. Other techniques such as XRay powder diffraction and NMR 
spectroscopies will be briefly presented. 
Chromatographic impurity fingerprints will be considered and described for the analysis of 
suspect samples of Cialis® and Viagra®. Once again, the possibility to predict the authenticity 
of a new sample by the mean of this technique is envisaged. 
Finally, a MS-compatible UHPLC-UV method for the analysis of the three authorised PDE5-i 
and some of their analogues will be shortly described. This technique has been validated 
using spiked placebo samples in a vegetal matrix representing a suspect sample with a 
complex matrix. 
As a conclusion, a generic strategy for the detection and quality evaluation of counterfeit 
drugs will be presented. 
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1. Introduction: 
The counterfeiting of medicines exists for millennia. At the first century of our era, Pedanius 
Dioscorides, a Greek physician, already warned about the dangers of adulterated drugs 
(WHO, 1999). Since then, many crises of falsification of medications have been documented 
(Newton et al., 2006). Most of those crises implicated falsified herbal medicines and resulted 
in many deaths due to the lack of efficacy and/or toxicity of adulterated drugs. Categories of 
adulterated drugs and the risks associated vary according to the region considered.  
 
In developing countries, the most counterfeited class of medicine is the anti-infective class 
(WHO, 2010). This represents a serious public health problem. Indeed, most of the 
population buy their drugs in the street at low prices. These drugs generally have less or no 
therapeutic activity. When treating diseases associated with a high untreated mortality such 
as malaria, pneumonia, meningitis, AIDS, typhoid and tuberculosis with inefficient drugs, 
mortality and morbidity increase. Moreover, the use of subtherapeutic amounts of active 
ingredients increases the risk of developing microbial resistance. In this case, even genuine 
drugs would be inefficient (Newton et al., 2006). 
 
In industrialized countries, the main counterfeited therapeutic categories are “lifestyle” drugs 
(weight loss drugs and potency drugs). The risks associated with these drugs are mostly due 
to the presence of toxic compounds or impurities, too high amounts of active ingredients, 
presence of unexpected active ingredient or new unknown designer drugs and wrong, 
missing or inadequate information concerning the use of the drug (RIVM, 2005). Other 
categories such as antineoplastic drugs or cardiovascular drugs have also been found to be 
counterfeited (FAMHP, 2010). The fact that counterfeit drugs may be found in the legal 
market constitutes a major public health risk. Indeed, besides the potential adverse effects 
encountered by the users, the patients may not trust medicines anymore, even if they are 
sold in pharmacy. A report of the WHO states that: “As а consequence of such damaging 
effects, counterfeit drugs may erode public confidence in health care systems, health care 
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professionals, the suppliers and sellers of genuine drugs, the pharmaceutical industry and 
national Drug Regulatory Authorities (DRAs). Incorrect labeling as to the source can also be 
detrimental to the reputation and financial standing of the original and/or current 
manufacturer whose name has been fraudulently used.” (WHO, 2009) 
 
2. Phosphodiesterase type 5 inhibitors 
In 1998, Pfizer (New York, USA) obtained the marketing authorisation for its new drug 
Viagra®. This product contains sildenafil citrate as active ingredient. A few years later, Lilly 
(Indianapolis, USA) launched Cialis® (containing tadalafil) in 2002 followed by Bayer 
(Leverkusen, Germany) with Levitra® (containing vardenafil hydrochloride) in 2003. These 
three drugs are the only authorised phosphodiesterase type 5 inhibitors (PDE5-i) for the 
treatment of erectile dysfunction. 
 
2.1. Pharmacodynamics: 
The physiological mechanism responsible for erection of the penis involves the release of 
nitric oxide (NO) in the corpus cavernosum during sexual stimulation. Nitric oxide then 
activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine 
monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and 
allowing inflow of blood resulting in erection.  
Phosphodiesterase type 5 (PDE5) is responsible for degradation of cGMP. When the 
NO/cGMP pathway is activated during a sexual stimulation, inhibition of PDE5 by the PDE5-i 
results in increased corpus cavernosum levels of cGMP. These high levels of cGMP induce a 
sustained erection. Therefore sexual stimulation is required since sildenafil has no direct 
relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant 
effect of NO on this tissue (Pfizer, 2010; Schoen et al., 2009).  
Actually, eleven families of phosphodiesterase have been identified. Each of these families 
exerts its role in specific localizations. Sildenafil, tadalafil and vardenafil have a relative 
selectivity towards PDE 5 and they may inhibit other PDE families in function of their local 
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concentrations. These inhibitions explain some of their undesirable effects such as the visual 
disturbances (inhibition of PDE6), inhibition of platelet aggregation and increased heart rate 
(inhibition of PDE3) or dyspepsia (inhibition of oesophageal PDE5) (Bischoff et al., 2004). 
 
2.2. History of PDE5-i counterfeiting 
Viagra® is one of the most counterfeited drugs in industrialized countries. This may be 
explained by the high prices and by the embarrassment caused by the medical consultation 
for an erectile dysfunction problem. Internet is an easy, fast and anonymous way to obtain 
these kinds of drugs.  
Only eighteen months after the approval of the genuine Viagra®, counterfeit tablets 
containing sildenafil appear. Tadalafil appeared in Viagra® counterfeits one month before the 
approval of Cialis® and one year after appeared the first counterfeits of Cialis®. In the 
Netherlands, in 2004, Viagra® counterfeits represented 98% of the PDE5-i illegal market and 
Cialis® the last two percent. In 2006, Viagra® represented only 69% of the illegal PDE5-i 
market while Cialis® (25%) and Levitra® (6%) have become more prevalent (RIVM, 2007).  
Besides these three approved molecules, numerous analogues exist. Most of them have 
been found as adulterants of herbal dietary supplement (RIVM, 2007). These analogues also 
show a relative selectivity towards the PDE5 (see table 1). However, their inhibition potency 
might be very different of the one of sildenafil and are rarely taken into account for their 
dosage in illegal preparations. Furthermore, the differences in their chemical structures lead 
to differences in their pharmacokinetic parameters such as their onset of action, blood levels, 
half-lives, brain penetration and metabolism. All these parameters are unknown for the 
analogues. This represents a huge toxicological risk linked to their intake especially when 












2.3. Definitions and classification 
The WHO defines a counterfeit medicine as: 
 “One that is deliberately and fraudulently mislabelled with respect to identity 
and/or source. Counterfeiting can apply to both branded and generic products. 
Counterfeit products may include products with the correct ingredients or with 
the wrong ingredients, without active ingredients, with insufficient (inadequate 
quantities of) active ingredient(s) or with fake packaging (WHO, 2009a)." 
The substandard medicines definition is the non-deliberate and genuine side of the 
counterfeit medicines definition:  
 “Substandard medicines (also called out of specification (OOS) products) are 
genuine medicines produced by manufacturers authorized by the NMRA 
(National Medical Regulatory Authority) which do not meet quality 
specifications set for them by national standards (WHO, 2009a).”  
Practically, illegal samples seized at the customs may be divided in two main groups 
(counterfeit or imitations) according their physical appearance. These two main groups are 
themselves subdivided in function of the chemical composition of the tablets. This 
classification, proposed by the Dutch National Institute for Public Health and the Environment 
(RIVM, 2007), is showed in table 2.  
Table 1 PDE5 in-vitro pharmacological potencies of the three 
approved PDE5-i and some of their analogues (data from 
(RIVM, 2007; Medsafe, 2009)) 
    
Compound 
Potency relative to the inhibition 
of PDE 5 by sildenafil 













Table 2: Classification of illegal medicines proposed by the Dutch National Institute for Public Health and the 
Environment (adapted from RIVM, 2007). 
Main category Subcategory Inclusion and exclusion criteria 
  Accurate Appearance in conformity with genuine medicine; 
    Content of correct API within 90 - 110 % of declared value; 
    No other APIs; not genuine medicine. 
  Non-Accurate Appearance in conformity with genuine medicine; 
    Content of correct API outside 90 - 110 % of declared value; 
    No other APIs. 
Counterfeit Mixed  Appearance in conformity with genuine medicine; 
   Contains correct API and another, known API 
  Fraudulent  Appearance in conformity with genuine medicine; 
    Contains a different, known API. 
  Analog  Appearance in conformity with genuine medicine, 
    Contains other, unapproved API 
  Placebo Appearance in conformity with genuine medicine; 
    Does not contain APIs. 
  Accurate Appearance not in conformity with genuine medicine; 
    Content of correct API within 90 - 110 % of declared value; 
    No other APIs. 
  Non-Accurate Appearance not in conformity with genuine medicine; 
Imitation 
  Content of declared API outside 90 - 110 % of declared value; 
   No other APIs. 
And  Mixed  Appearance not in conformity with genuine medicine; 
  
  Contains declared API and another API. 
 Food 
Supplements Fraudulent  Appearance not in conformity with genuine medicine; 
 
  Contains an undeclared API. 
 Analog  Appearance not in conformity with genuine medicine; 
    Contains other, unapproved API 
  Placebo Appearance not in conformity with genuine medicine; 
    Does not contain APIs. 
 
3. Detection of counterfeit PDE5-i drugs: 
Several analytical techniques have already been used for the detection of counterfeit PDE5-i 
most of them are fingerprinting methods. These techniques are separated in two main 
groups: spectroscopic and chromatographic techniques.  
 
3.1. spectroscopic techniques 
Spectroscopic techniques study the interaction between an electromagnetic radiation and the 
matter. These techniques are classified according to the region of the electromagnetic 
spectrum measured.  
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Techniques such as Raman and Near Infrared (NIR) spectroscopy are becoming more and 
more used for the detection of counterfeit medicines. This is explained by their rapidity and 
easiness of use. Moreover only a little sample preparation or no preparation at all is needed 
and these methods are non destructive (Rodionova et al., 2010). For the detection of 
counterfeit drugs, the signals obtained with spectroscopic techniques must be pre-treated 
and analysed by chemometric clustering tools such as principal component analysis (PCA) to 
extract understandable and useful information from the spectra. The data analysis is the only 
way to come to unambiguous and objective conclusions.  
 
Raman spectroscopy 
Raman spectroscopy studies the radiation scattered by a sample when irradiated with a 
monochromatic radiation. It may be used in the elucidation of a molecular structure and is a 
complementary technique to mid-IR and NIR spectroscopies. Indeed, a vibrational mode is 
Raman active when there is a change in polarisability during the vibration whether it is mid-IR 
and NIR active when there is a change in the molecular dipole moment during the vibration. 
Thus, a vibrational mode that is highly Raman active will be weakly mid-IR active and vice 
versa (Bugay et al., 2004). 
 
de Veij et al. (2008) recorded the Raman spectra (between 700-1800 cm-1) of eighteen 
suspect samples and one genuine sample. They were able to check the presence of 
sildenafil and some of the excipients by visual inspection of the Raman spectra. This visual 
inspection permitted the discrimination of two groups among the counterfeits but not to 
distinguish them from the genuine one. Therefore, hierarchical cluster analysis (HCA) and 
PCA analysis were performed. The combination of these two techniques allowed the 
complete discrimination between genuine and counterfeit tablets. Raman spectroscopy has 
also been used to analyse Cialis® counterfeits in association with 1H NMR and 2D Diffusion 
Ordered Spectroscopy (DOSY) 1H NMR (Trefi et al., 2008). Seven counterfeits and one 
genuine tablet were analysed. The presence of characteristic bands in the Raman spectra 
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corresponding to unusual excipients confirmed that the analysed samples were 
counterfeited. The identity of these excipients was confirmed by the NMR spectra providing a 
“signature” of the manufacturer which could be useful in sourcing studies. 
 
 Near infrared (NIR) spectroscopy 
The NIR region of the electromagnetic spectrum is comprised between 12500 and 4000 cm-1 
(800-2500 nm). While the mid-IR absorbances correspond mainly to fundamental vibrations, 
the NIR absorbances correspond to overtones (excitation of a vibration to a double or higher 
frequency) and combinations of molecular vibrations. This is why the interpretation of NIR 
spectra is more difficult than mid-IR spectra.  
NIR spectra are essentially used for qualitative analysis because of their fingerprint nature 
and the fact that NIR spectra contain both chemical and physical informations. (Jee, 2004). 
 
The analysis by NIR spectroscopy of 103 samples containing sildenafil citrate (in the range of 
12000-3000 cm-1) allowed the detection of counterfeit samples based on the wavelength 
correlation applied on spectra without pre-treatment (threshold value of 0.998). Analysts 
were also able to predict the presence of sildenafil citrate in 98% of the samples 
(Vredenbregt et al.,2006). 
 
Fourier transform mid-infrared (FT-IR) spectroscopy 
When irradiating a sample with a mid-IR radiation (wavenumbers of 4000-400 cm-1), a part of 
the energy is absorbed by the molecules. If the energy is sufficient, the molecular bonds go 
up to an excited state of energy. The amount of energy needed to excite a molecular bond 
depends on the atoms involved and the strength of the bond. This is very useful to detect the 
existence of functional groups in a molecule. Indeed, a specific wavelength radiation will 
excite specific bonds. This opportunity to identify functional groups in a molecule is only 
possible within the 4000-1800cm-1 region. Indeed, in the 1800-400 cm-1 region (fingerprint 
region), too many peaks are present and are therefore hardly assigned to specific functional 
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groups. It may, on the other hand, be used as a specific fingerprint of the analysed molecule 
for the identification of pure compounds or the identification of specific mix of compounds 
(such as tablets). 
The fingerprint region of the FT-IR spectrum has been successfully used for the detection of 
counterfeit Viagra® and Cialis® tablets (Sacré et al., 2010). Transmittance spectra of 55 
Viagra-like samples and 9 genuine Viagra® were measured using KBr disks. Then, Partial 
Least Square (PLS) analysis has been performed on the normalized spectra. The same 
procedure has been applied on 39 Cialis-like samples and 4 genuine Cialis®. A good 
discrimination between genuine and illegal samples has been obtained in both cases. 
 
Combination of infrared spectroscopic methods 
Sacré et al. (2010) investigated which technique (FT-IR, NIR or Raman spectroscopy) or 
combination of these techniques was the best to (1) detect counterfeit Viagra® and 
counterfeit Cialis® and (2) to make clusters in illegal medicines. They found that the 
combination of FT-IR (1800-400 cm-1) and NIR (700-4000 cm-1) spectroscopies provides the 
best results for the analysis of illegal drugs containing sildenafil citrate while the combination 
of NIR (700-4000 cm-1) and Raman (1400-1190 cm-1) spectroscopies was the best for the 
analysis of medicines containing tadalafil as active pharmaceutical ingredient (API). 
However, these conclusions were obtained by visual inspection of the PLS factors plots. 
Therefore, Classification And Regression Trees (CART) algorithm was applied on the 
infrared datasets in order to discriminate between genuine and counterfeit drug samples and 
to classify counterfeit samples in different classes following the RIVM classification system 
(Deconinck et al., 2012). The different models were validated for their descriptive and 
predictive properties.  
For the Viagra-like samples, the best results were obtained with two comparable models 
based on the FT-IR and the NIR spectra respectively. Both models returned a 100% correct 
classification rate (CCR) for the discrimination between genuine and counterfeit tablets 
during both internal and external validation. The models have cross validation errors of 
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11.6% and 14.4% respectively and equal misclassification rates of 2/12 after external 
validation for the classification of the samples in their respective RIVM class. The 
combination of the different types of spectroscopic data did not result in better models 
compared to the ones obtained with only FT-IR or NIR data. 
For the Cialis-like samples, the best model has been obtained combining NIR and Raman 
spectroscopy. This model gives 77,5% CCR during internal validation but 100% CCR during 
external validation.  
The results obtained with PLS are comparable to the results of the CART models. However, 
CART also allows a clear discrimination of the counterfeit samples in different classes. This 
possibility of classifying new unknown samples in their respective RIVM class allows a fast, 
easy and reliable overview of their risk for public health (Sacré et al., 2010). 
 
Raman Microspectroscopy imaging 
Chemical imaging is a powerful tool that combines physico-chemical information and spatial 
information of the sample. Raman microspectroscopy allows a complete mapping of a limited 
area of a tablet with a limited sample preparation. The maps of 26 counterfeits and imitations 
of Viagra® tablets and 8 genuine tablets of Viagra® were recorded (Sacré et al., 2011a). The 
different maps were pre-processed to allow multivariate analysis.  
Three different analyses were performed: 
 discrimination between genuine and illegal samples based on the whole Raman 
spectrum (200-1800cm-1). 
 discrimination between genuine and illegal samples based on the presence of lactose 
in the core of the tablets (830-880 cm-1). Lactose is not present in the core of genuine 
Viagra® tablets but is a common and cheap filler probably used by counterfeiters.  
 discrimination between genuine and illegal samples based on the distribution of 
sildenafil among the core of the tablets (1200-1290 cm-1). It is therefore expected that 
the spatial distribution of sildenafil is less homogenous in illegal tablets than in 
genuine ones.  
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PCA analysis performed between the 200-1800cm-1 and the 830-880 cm-1 spectral range 
(Figures 1 and 2) show a clear discrimination between genuine and illegal tablets. In the 830-
880 cm-1 region, genuine tablets shows no peak because lactose is not present in the core of 
genuine Viagra® tablets whereas illegal samples show two peaks at 851 and 876 cm-1. These 
two peaks are attributed to lactose (de Veij et al., 2008; Degelder et al., 2007).  
Figure 1: PCA plots of the Raman microspectroscopy data between the 200-1800cm-1 spectral range dataset. 
Black dots are illegal samples and blue circles are genuine Viagra® samples. 
Figure 2: PCA plots of the Raman microspectroscopy data between the 830-880cm-1 spectral range dataset. This 
spectral region corresponds to lactose peaks. Black dots are illegal samples and blue circles are genuine Viagra® 
samples. 
 
No discrimination has been obtained by the multivariate analysis of the spectral region 
corresponding to the peak of sildenafil revealing that the spatial distribution of sildenafil 
between illegal and genuine samples is not sufficiently different. 
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k-Nearest Neighbour (k-NN) algorithm has been applied on the spectral regions of 200-1800 
cm-1 dataset. 100% correct classification rate has been obtained during both internal and 
external validation confirming the ability of Raman microspectroscopy to detect counterfeit 
Viagra samples. 
 
X-Ray (XR) and Nuclear Magnetic Resonance (NMR) 
X-Ray powder diffraction (XRD) allowed Maurin et al. (2007) to identify sildenafil and the two 
most concentrated excipients (microcrystalline cellulose and anhydrous calcium hydrogen 
phosphate) in suspect Viagra® samples. The discrimination between fake and original tablets 
can be easily done, even visually, by comparison of diffraction patterns. The diffraction 
patterns may be used as fingerprints of a given pharmaceutical (legal or not) since it is a 
superposition of the patterns from all crystalline components of this product. XRD does not 
require any sample preparation, is relatively fast (~45 min) and do not require advanced 
statistical treatment of the data to obtain useful information.  
Recently, Ortiz et al. (2012) analysed imitations and counterfeit sildenafil citrate and tadalafil 
tablets by X-Ray Fluorescence spectrometry (XRF). XRF is mainly used in the 
pharmaceutical industry to characterize the presence of metals. This technique may be 
applied to a wide variety of samples and has many advantages among which its high 
precision, good detectivity, short analysis times and its non destructive character. The 
authors were able to perform semi-quantitative determination of the active ingredient 
(sildenafil is detected by the presence of sulphur) and excipients such as calcium phosphate, 
titanium oxide and iron oxide (Ca, P, Ti, Fe). Applying PCA and HCA on the data allowed the 
distinction of seven groups of samples mainly due to differences in their Ca and Ti content.  
Trefi et al. (2009) used 2D DOSY and 3D DOSY-COrrelation SpectroscopY (COSY) 1H NMR 
to analyse counterfeit Viagra® samples. They were able to identify different active ingredients 
and various excipients in a single experiment. The biggest advantage of this technique is the 
amount of information available while the duration of measurement remains reasonable 
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(~2h). However, mineral components are not detected, it can only analyse compounds 
soluble in the NMR solvents and it requires highly trained analysts to interpret the spectra. 
Another disadvantage, common to both NMR and X-Ray diffraction is the cost of equipments 
which can, therefore, not be present in the majority of control laboratories. 
 
Visible light based techniques 
The visible light range of the electromagnetic spectrum (380-730 nm) may also be used for 
detecting counterfeit drugs. Rodomonte et al. (2010) investigated the possibility to use the 
secondary packaging or the tablet colour as discriminating parameter. They analysed ten to 
twenty batches for each dosage of genuine Viagra®, Cialis® and Levitra®. The reflectance 
visible spectrum was measured on the less carved side of the tablets and on the more 
distinctive colour of secondary packages (green for Cialis®, violet for Levitra® and blue for 
Viagra®). The method was validated (ruggedness, repeatability and inter-operator and inter-
day precision). The built model allowed the authors to detect counterfeit samples. This 
colorimetric method may be used as very first step during the visual inspection of samples as 
it is very fast, inexpensive portable and easy to use.  
Photographs of Viagra® and Cialis® tablets have been used to detect counterfeit tablets 
(Jung et al., 2012). Photographs of 19 genuine and 24 counterfeit tablets of Viagra® and 20 
genuine and 53 counterfeit tablets of Cialis® were obtained using Video Spectral Comparator 
(VSC) in order to acquire images with the same conditions (illumination, lens, …) Images 
were then segmented and transformed in a statistical model based on the RGB (Red-Green-
Blue) colour component. The similarity of the statistical distributions has been measured and 
compared between all samples and a threshold value has been calculated. Validation of the 
model resulted in 100% classification accuracy for Viagra® samples while Cialis® samples 




These two techniques based on visible light have limitations. The colour of both tablets and 
secondary packaging may be altered (even for genuine drugs) by conservation conditions. 
This may lead to a higher False Positive rate. The biggest problem is that if counterfeiters 
produce packaging or coatings of very high quality, their products may be recognised as 
genuine tablets no matter their physico-chemical quality. Therefore, the results obtained with 
these techniques should imperatively be confirmed by another technique analysing the 
content of the tablet. 
 
3.2. Chromatographic techniques 
Chromatography enables the separation, identification and quantification of chemical 
compounds. In the field of counterfeit PDE5-i analysis, reversed phase high performance 
liquid chromatography (RP-HPLC) is the most used technique to identify new analogues and 
to quantify API in suspect tablets. Generally, the mobile phase is a combination of acidic 
aqueous phase and acetonitrile as organic modifier while octadecylsilane (C18) is employed 
as stationary phase (Singh et al., 2009). A range of detectors can be used, where mass 
spectrometers and diode array detectors (DAD) are the preferred ones. 
Reference draft methods have been published in Pharmeuropa for both sildenafil citrate and 
tadalafil (EDQM, 2010; EDQM, 2011). The sildenafil citrate assay method is performed on a 
HPLC system with an endcapped C18 stationary phase column of 150 x 3,9 mm and 5 µm 
particle size. Mobile phase is constituted by a mixture of 17 volumes acetonitrile, 25 volumes 
methanol and 58 volumes of a 0,7 % (V/V) solution of triethylamine adjusted at pH 3,0 (+/- 
0,1) with phosphoric acid. The analysis is performed at 30°C with a flow rate of 1mL/min. An 
aliquot of 20 µL of a solution containing 20 µg/mL of sildenafil base (~ 28 µg/mL sildenafil 
citrate) is injected and the detection is performed at 290nm.  
The tadalafil assay method is performed on a HPLC system with a sterically protected 
diisopropyl-C8 stationary phase column of 250 x 4,6 mm and 5 µm particle size. Mobile 
phase is constituted by a mixture of 45 volumes acetonitrile and 55 volumes of a 0,1% (V/V) 
solution of trifluoroacetic acid. The analysis is performed at 40°C with a flow rate of 1,5 
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mL/min. An aliquot of 20 µL of a solution containing 100 µg/mL of tadalafil is injected and the 
detection is performed at 285 nm. 
 
Chromatographic impurity fingerprints 
The treatment of chromatographic data as fingerprints is widely used in the field of 
pharmacognosy for quality control of plants (Xu et al., 2006). Chromatographic fingerprints 
allow a reliable evaluation of the quality and the identity of plant extracts even if neither the 
identity nor the quantity of the constituents are known.  
 
In the frame of counterfeit drug detection, chromatographic impurity fingerprints is interesting. 
Indeed, a major hazard of counterfeit products is the presence of toxic impurities in unknown 
amount. Therefore, as it is the case for herbal medicines, the fingerprint approach allows the 
discrimination of tablets according to their chromatographic profiles without knowing a priori 
neither the identity nor the quantity of the constituents. Furthermore, it provides a general 
overview of the chemical composition of the drug with a possibility of identification of the 
active compounds or impurities and the simultaneous quantification of the active compounds. 
However, to obtain good and reliable results, a pre-processing step is crucial. This step is 
mainly composed of signal enhancement, warping and mixture analysis. 
 
A chromatogram contains three major components: 
 Noise (highest frequency component) 
 Signal (intermediate frequency component) 
 Background (lowest frequency component) 
If needed, noise and background components are eliminated to enhance the signal. But the 
biggest challenge is due to the shift in retention times that appears when performing several 
chromatographic analyses. This shift is mainly due to stationary phase degradation, 
temperature variations and fluctuations in mobile phase composition. Several alignment 
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techniques exist (Daszykowski et al., 2006) and each of them should be tested in order to 
obtain the best results. 
Sacré et al. (2011a) have analysed 73 Viagra-like samples and 44 Cialis-like samples on a 
HPLC system with dual UV detector. The chromatograms were obtained on the same HPLC-
UV system with the same mobile phase (Figure 3).  
a.               b. 
    
c.                d. 
    
Figure 3:  
a. Impurity profile of a counterfeit tablet of Viagra® 
b. Impurity profile of a genuine tablet of Viagra® 
c. Impurity profile of a coloured imitation tablet of Cialis® 
d. Impurity profile of a genuine tablet of Cialis®. 
 
However, a shift in retention times was present and the chromatograms needed an alignment 
prior any multivariate analysis. For each speciality, chromatograms were aligned in function 
of the major (largest) peak. Once aligned, the chromatograms underwent logarithmic 
transformation in order to reduce the influence of remaining slight differences and baseline 
perturbations. After pre-treatment, PLS was applied on each dataset. The score plots 

















a.       b. 
 
 
Figure 4:  
a. PLS three dimensional plot of the log transformed impurity profiles of the Viagra® dataset. Black points 
are the illegal samples and blue circles are the genuine ones. 
b. PLS2-PLS3 plot of the log transformed impurity profiles of the Cialis® dataset. Black points are the illegal 
samples and blue circles are the genuine ones. 
 
Predictive models were built using the k-nearest neighbour algorithm (k-NN) and validated. 
For the Viagra dataset, k-NN classifier allows 100% of correct classification rate in both 
internal and external validation whether for the Cialis dataset, it returns 92,3% and 100% 
during internal and external validation respectively. 
The results showed that impurity fingerprints can be an interesting approach for the detection 
of counterfeit drugs. 
 
UHPLC-UV method 
Liquid chromatography remains the gold standard technique to separate active compounds 
and to quantify them in pharmaceutical preparations. If fingerprinting methods have classified 
a suspicious sample as counterfeit, one needs to confirm the identity of the API and to 
quantify it to know to which RIVM class (and therefore the public health risk associated) it 
belongs. The same is true to classify a new sample and to detect new analogues. It is 
therefore interesting to have a generic method able to detect and quantify the three 
authorised PDE5-i and their analogues.  
Sacré et al. (2011b) developed and validated a UHPLC method able to analyse sildenafil, 




Figure 5: Chromatogram obtained by applying the gradient conditions for the UHPLC method developed by 
Sacré et al. (2011b) 
 
The UHPLC gradient was performed on an AcquityTM BEH Shield RP18 (100 mm x 2.1 mm, 
1.7 µm particle size) column. Mobile phase A consisted of a 10 mM ammonium formate 
buffer (pH 3.5) and mobile phase B was acetonitrile. The gradient conditions are presented in 
table 3.  
Table 3 : Gradient conditions (Sacré et al., 2011b) 
 
Time 
(min) Flow rate (ml/min) % A % B 
    
0 0.55 75 25 
2.5 0.55 65 35 
3.5 0.55 55 45 
3.8 0.55 30 70 
4.5 0.55 30 70 
5.0 0.55 75 25 
    
 injection volume: 1.5µl  
 Column temperature: 40°C  
    
The analogues of the registered API’s were chosen according to their availability and their 
structural differences. The diastereoisomer of tadalafil, (-)-trans-tadalafil, was produced in the 
laboratory starting from tadalafil as no standard was commercially available.  
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Therefore, it was not quantified but its separation from the other peaks is important since it is 
frequently present in illegal preparations as an impurity.  
The method has been validated using the total error approach (Hubert et al., 2004; Hubert et 
al., 2007a; Hubert et al., 2007b; Hubert et al., 2008). Spiked herbal matrix placebos were 
used as validation samples. This is justified by the fact that the method could be applied to a 
great variety of matrixes (among them, vegetal matrixes are the most complex) and that 
analogues are essentially found in vegetal alimentary complements. The validation 
acceptance limits were set at +/- 5% as for pharmaceutical specialities. Once developed and 
validated, the method has been compared to the reference draft method published in 
Pharmeuropa (EDQM, 2011). This comparison showed that both methods gave comparable 
results. The elucidation of structures and the confirmation of identity may be performed by 
LC-MS systems since the mobile phase is compatible. The method has already been applied 
to real samples and showed no interference with common other substances present as 
yohimbine (retention time of 0.77 min) and caffeine (retention time of 0.57 min). 
 
4. Conclusion 
Counterfeit medicines become more and more sophisticated as well the packaging (i.e. 
holograms etc.) as the tablet itself. Customs must therefore use more and more 
sophisticated analytical techniques. Among them a difference must be made between the 
expensive and complicated ones available in industrialized countries and the less efficient 
and cheaper ones available in developing countries while these countries are the most 
affected by the counterfeiting problem. As counterfeit erectile dysfunction drugs are mainly a 
problem of industrialized countries, the developed methods use apparatus available in 
control laboratories of these countries.  
These results obtained with the different techniques described in this chapter indicate that 
control laboratories can, in function of their equipment, implement fast, easy and reliable 
detection of illegal preparations. However, the reliability of the results is dependent of the 
database upon which the model is based.  
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The bigger and diversified the database is, the more reliable are the results. 
Therefore, before starting to analyse new samples, laboratories must analyse a minimum 
number of genuine and illegal preparations. As time goes by, each new analysed sample 
could be included in the database and the models rebuilt. Each laboratory could then have a 
powerful model of classification adapted to the kind of medication analysed.  
 
To conclude, a generic approach to detect counterfeit drugs containing PDE5-i is proposed 
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Figure 6 : General strategy for the detection and classification (RIVM) of samples suspected to contain PDE5-i. 
 
When a new sample arrives in the laboratory for analysis, the visual inspection is the first 
analysis performed (eventually helped with colorimetry analysis). If the samples do not look 
like genuine drug or if it is a dietary supplement, the only analysis to perform is a qualitative 
and quantitative analysis using UHPLC-UV and/or LC-MS method. Indeed, no fingerprinting 
method is necessary since it is evident that it is not a genuine drug. Using the obtained 
information, it is therefore possible to classify the sample following the RIVM classification 
(see table 3). 
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If the new sample has the same appearance as genuine Viagra® or Cialis®, a fingerprinting 
method is the first recommended analysis. Prior to any fingerprinting analysis, the control 
laboratory must have developed and validated a predictive model based on the fingerprints 
of a sufficient number of genuine and illegal samples. Thereafter, each new measured 
sample will be added to the database and the predictive model rebuilt and revalidated. As 
time goes by, the model will be more and more accurate as its database grows. 
Two kind of fingerprinting approaches are available: spectroscopic and chromatographic 
fingerprinting.  
Spectroscopic fingerprinting is quick, non destructive and reproducible. However, not every 
laboratory has a NIR or a Raman spectrometer and the apparatus are quite expensive.  
On the other hand, chromatographic fingerprinting allows chemical analysis of the tablets 
and the identification of potential toxic impurities while simultaneously quantifying the active 
ingredient(s). Another advantage is that these fingerprints are obtained on classical HPLC-
UV systems present in every control laboratory. However, the main drawbacks are the fact 
that it is a time consuming method and that a lot of parameters may change (mobile phase 
composition, different analytical columns, ageing of stationary phase, different HPLC system, 
etc.). All these parameters introduce changes in chromatograms, complicating data 
alignment and pre treatment. In conclusion, we recommend the use of spectroscopic 
fingerprinting methods. If the tablet has been declared counterfeit, it undergoes quantitative 
and qualitative analysis with UHPLC-UV and/or LC-MS method and is classified following the 
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